730 related articles for article (PubMed ID: 20189638)
1. HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage.
Mathers BM; Degenhardt L; Ali H; Wiessing L; Hickman M; Mattick RP; Myers B; Ambekar A; Strathdee SA;
Lancet; 2010 Mar; 375(9719):1014-28. PubMed ID: 20189638
[TBL] [Abstract][Full Text] [Related]
2. Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review.
Larney S; Peacock A; Leung J; Colledge S; Hickman M; Vickerman P; Grebely J; Dumchev KV; Griffiths P; Hines L; Cunningham EB; Mattick RP; Lynskey M; Marsden J; Strang J; Degenhardt L
Lancet Glob Health; 2017 Dec; 5(12):e1208-e1220. PubMed ID: 29074410
[TBL] [Abstract][Full Text] [Related]
3. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews.
Nelson PK; Mathers BM; Cowie B; Hagan H; Des Jarlais D; Horyniak D; Degenhardt L
Lancet; 2011 Aug; 378(9791):571-83. PubMed ID: 21802134
[TBL] [Abstract][Full Text] [Related]
4. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review.
Degenhardt L; Peacock A; Colledge S; Leung J; Grebely J; Vickerman P; Stone J; Cunningham EB; Trickey A; Dumchev K; Lynskey M; Griffiths P; Mattick RP; Hickman M; Larney S
Lancet Glob Health; 2017 Dec; 5(12):e1192-e1207. PubMed ID: 29074409
[TBL] [Abstract][Full Text] [Related]
5. Availability of HIV prevention and treatment services for people who inject drugs: findings from 21 countries.
Petersen Z; Myers B; van Hout MC; Plüddemann A; Parry C
Harm Reduct J; 2013 Aug; 10():13. PubMed ID: 23957896
[TBL] [Abstract][Full Text] [Related]
6. Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs.
Platt L; Minozzi S; Reed J; Vickerman P; Hagan H; French C; Jordan A; Degenhardt L; Hope V; Hutchinson S; Maher L; Palmateer N; Taylor A; Bruneau J; Hickman M
Cochrane Database Syst Rev; 2017 Sep; 9(9):CD012021. PubMed ID: 28922449
[TBL] [Abstract][Full Text] [Related]
7. What has been achieved in HIV prevention, treatment and care for people who inject drugs, 2010-2012? A review of the six highest burden countries.
Degenhardt L; Mathers BM; Wirtz AL; Wolfe D; Kamarulzaman A; Carrieri MP; Strathdee SA; Malinowska-Sempruch K; Kazatchkine M; Beyrer C
Int J Drug Policy; 2014 Jan; 25(1):53-60. PubMed ID: 24113623
[TBL] [Abstract][Full Text] [Related]
8. Global coverage of interventions to prevent and manage drug-related harms among people who inject drugs: a systematic review.
Colledge-Frisby S; Ottaviano S; Webb P; Grebely J; Wheeler A; Cunningham EB; Hajarizadeh B; Leung J; Peacock A; Vickerman P; Farrell M; Dore GJ; Hickman M; Degenhardt L
Lancet Glob Health; 2023 May; 11(5):e673-e683. PubMed ID: 36996860
[TBL] [Abstract][Full Text] [Related]
9. Coverage to curb the emerging HIV epidemic among injecting drug users in Pakistan: delivering prevention services where most needed.
Emmanuel F; Fatima M
Int J Drug Policy; 2008 Apr; 19 Suppl 1():S59-64. PubMed ID: 18281206
[TBL] [Abstract][Full Text] [Related]
10. Access and coverage of needle and syringe programmes (NSP) in Central and Eastern Europe and Central Asia.
Aceijas C; Hickman M; Donoghoe MC; Burrows D; Stuikyte R
Addiction; 2007 Aug; 102(8):1244-50. PubMed ID: 17565564
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness and cost effectiveness of expanding harm reduction and antiretroviral therapy in a mixed HIV epidemic: a modeling analysis for Ukraine.
Alistar SS; Owens DK; Brandeau ML
PLoS Med; 2011 Mar; 8(3):e1000423. PubMed ID: 21390264
[TBL] [Abstract][Full Text] [Related]
12. Treatment and care for injecting drug users with HIV infection: a review of barriers and ways forward.
Wolfe D; Carrieri MP; Shepard D
Lancet; 2010 Jul; 376(9738):355-66. PubMed ID: 20650513
[TBL] [Abstract][Full Text] [Related]
13. Correlates of syringe coverage for heroin injection in 35 large metropolitan areas in the US in which heroin is the dominant injected drug.
Tempalski B; Cooper HL; Friedman SR; Des Jarlais DC; Brady J; Gostnell K
Int J Drug Policy; 2008 Apr; 19 Suppl 1(Suppl 1):S47-58. PubMed ID: 18295468
[TBL] [Abstract][Full Text] [Related]
14. HIV transmission in Bangladesh: an analysis of IDU programme coverage.
Reddy A; Hoque MM; Kelly R
Int J Drug Policy; 2008 Apr; 19 Suppl 1():S37-46. PubMed ID: 18207724
[TBL] [Abstract][Full Text] [Related]
15. Towards combination HIV prevention for injection drug users: addressing addictophobia, apathy and inattention.
Strathdee SA; Shoptaw S; Dyer TP; Quan VM; Aramrattana A;
Curr Opin HIV AIDS; 2012 Jul; 7(4):320-5. PubMed ID: 22498479
[TBL] [Abstract][Full Text] [Related]
16. Potential impact of implementing and scaling up harm reduction and antiretroviral therapy on HIV prevalence and mortality and overdose deaths among people who inject drugs in two Russian cities: a modelling study.
Cepeda JA; Eritsyan K; Vickerman P; Lyubimova A; Shegay M; Odinokova V; Beletsky L; Borquez A; Hickman M; Beyrer C; Martin NK
Lancet HIV; 2018 Oct; 5(10):e578-e587. PubMed ID: 30033374
[TBL] [Abstract][Full Text] [Related]
17. [Intravenous drug use and the spread of HIV; an international perspective].
Meijerink H; van Crevel R; van der Ven AJ
Ned Tijdschr Geneeskd; 2013; 157(21):A5690. PubMed ID: 23693006
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of high-risk drug use and coverage of opioid substitution treatment and needle and syringe programs in Lithuania in 2015-2016: A multi-method estimation study.
Thanki D; Mravčík V; Běláčková V; Mačiulytė D; Zábranský T; Širvinskienė A; Subata E; Lorenzo-Ortega R
J Subst Abuse Treat; 2021 Mar; 122():108229. PubMed ID: 33509418
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of injecting drug use and HIV, hepatitis B, and hepatitis C in people who inject drugs in the Eastern Mediterranean region: a systematic review and meta-analysis.
Aghaei AM; Gholami J; Sangchooli A; Rostam-Abadi Y; Olamazadeh S; Ardeshir M; Baheshmat S; Shadloo B; Taj M; Saeed K; Rahimi-Movaghar A
Lancet Glob Health; 2023 Aug; 11(8):e1225-e1237. PubMed ID: 37474230
[TBL] [Abstract][Full Text] [Related]
20. Antiretroviral treatment for injecting drug users in developing and transitional countries 1 year before the end of the "Treating 3 million by 2005. Making it happen. The WHO strategy" ("3 by 5").
Aceijas C; Oppenheimer E; Stimson GV; Ashcroft RE; Matic S; Hickman M
Addiction; 2006 Sep; 101(9):1246-53. PubMed ID: 16911723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
